News | News By Subject | News by Disease News By Date | Search News

News By Date

Get Our FREE
Industry eNewsletter
News By Date


Tuesday, May 30, 2017

Top Breaking News
Cambridge Biotech Enumeral Biomedical (ENUM) Has Cash to Fund Its Operations Only Into Next Month
Bay Area Biotech Inks IBS Deal Worth $990 Million With Drug Giant Johnson & Johnson (JNJ)
Investors Antsy as Novartis AG (NVS) Mulls Over Selling $50 Billion in Assets
23andMe Recruited 5,000+ Women for Fertility Study in Just 9 Days
Talent Pool is Why German Biotech Evotec AG (EVTG.F) Chose New Jersey for Its U.S. HQ
Why This Tiny SoCal Biopharma Could be a Real Threat to Mylan (MYL)
Why June Could be a Pivotal Month for These 2 Biotechs
Kite Pharma (KITE) Catches Up With Novartis AG (NVS) as CAR-T BLA Gets Priority Review Status
FDA Rejects Sunovion's COPD NDA for SUN-101/eFlow
WuXi Healthcare Ventures and Frontline BioVentures Join Forces to Form 6 Dimensions Capital, a Leading China and U.S. Focused Investment Group Specializing in Healthcare and Life Sciences
This Company Admitted Failure—and the Stock Market Rewarded it
Recruiting Veterans for Life Science Jobs is a Focus at BIO

News from Around the Web

Press Releases
Novartis AG (NVS) Receives FDA Approval For Expanded Use Of Zykadia In First-Line ALK-Positive Metastatic Non-Small Cell Lung Cancer (NSCLC)
Sobi Canada (B6E.F) Release: Kineret Approved In Canada For The Treatment Of Neonatal-Onset Multisystem Inflammatory Disease (NOMID)
Merck & Co. (MRK) Receives FDA Approval Of ISENTRESS HD (Raltegravir), A New Once-Daily Option, In Combination With Other Antiretroviral Agents, For The Treatment Of HIV-1 Infection In Appropriate Patients
Sunovion Receives Complete Response Letter From FDA For SUN-101/eFlow (Glycopyrrolate) New Drug Application For Chronic Obstructive Pulmonary Disease (COPD)
TaiGen Biotechnology Announces Submission Of New Drug Application For Taigexyn Intravenous Formulation To The China Food And Drug Administration
Lysogene Completes Enrollment In First International Pivotal Observational Study In MPS IIIA
AMO Pharma Announces FDA Fast Track Designation For AMO-02 For Treatment Of Congenital Myotonic Dystrophy
Intensity Therapeutics, Inc. Successfully Administers INT230-6 To First Patient In A Phase I/II Trial
Resverlogix (RVX.TO) Receives Approval From Health Canada To Proceed With Fabry Disease Clinical Trial With Lead Compound Apabetalone
X-Biotix License Harvard Technology, Establishes Research Collaboration To Combat Antibiotic Resistance
Advaxis (ADXS) And Bristol-Myers Squibb (BMY) Announce Clinical Collaboration To Evaluate ADXS-DUAL And Opdivo (Nivolumab) In Metastatic Cervical Cancer
Array BioPharma (ARRY) And Bristol-Myers Squibb (BMY) Announce Strategic Collaboration
Arcturus Therapeutics To Receive Up To $3 Million From Cystic Fibrosis Foundation Therapeutics, Inc. To Advance A Novel LUNAR-Formulated mRNA CFTR Therapeutic
StemCyte, Inc. Renewed Strategic Partnership With The Neonatal Research InstituteSharp Mary Birch Hospital For Women & Newborns
Sierra Oncology Granted US. And EU Patents For Chk1 inhibitor SRA737
Daiichi Sankyo And Inspirion Delivery Sciences Announce Plans For Commercialization Of RoxyBond (Oxycodone Hydrochloride) Tablets CII In The U.S.
Vedanta Biosciences Granted U.S. Patent Broadly Covering Methods Of Treatment With Therapeutics Based On Bacterial Spore Fractions Of Microbiota Obtained From Human Donors
NuGEN Announces Issuance Of U.S. Patent For Its Single Primer Target Enrichment Technology (SPET) For Next Generation Sequencing Applications
Immune Pharma Receives Nasdaq Letters
Quotient Clinical Appoints Azhar Kalim As Chief Commercial Officer
Alkermes (ALKS) Appoints Craig Hopkinson, M.D., As Chief Medical Officer, And Senior Vice President, Clinical Development And Medical Affairs
Concert Pharma (CNCE) Announces Departure Of Chief Financial Officer, Ryan Daws
Veristat Congratulates Tesaro (TSRO) On The FDA Approval Of ZEJULA
Silicon Therapeutics Announces Recipient Of The First Open Science Fellowship
Poxel (POXEL.PA) To Present New Preclinical Imeglimin Data On Protective Benefits From Diabetic Cardiomyopathy At American Diabetes Association Meeting
GlaxoSmithKline (GSK), Medtronic (MDT) Back Saluda Med's Nearly $40 Million Series D Funding Round
Mobidiag Extends Distribution Agreement With PerkinElmer (PKI) To Offer Amplidiag Diagnostics Products In African Countries And Israel
iMCO Technology Release: CoWatch Maker Announces 'Best Value Fitness Tracker'
Covalon Technologies Ltd. Releases Second Quarter Financial Results
Dr. Eric G. Mortensen, M.D., Ph.D., Clinical Trial Veteran, Joins CytoSorbents As Chief Medical Officer